Blog - Page 1125 of 5714

MondayDec 20, 2021 12:08 pm

RYAH Group Inc. (CSE: RYAH) Releases Medical Cannabis Report on Cancer and Adverse Cancer Treatment Effects

RYAH recently released report highlighting medical cannabis treatment for cancer and adverse effects of cancer treatment Data from 80,000 sessions logged between January 1, 2018 and November 15, 2021 tracked conditions including anxiety, cachexia, fatigue, pain, nausea, and stress 62% of patients reported a moderate experience using cannabis to treat cancer-related conditions RYAH supports cancer research and treatment with IoT product ecosystem comprised of volume-control devices, medicine-carrying components, mobile applications RYAH Group (CSE: RYAH), the leader in volume-control technology for plant-based medicine, recently released a medical cannabis report on cancer and the adverse effects of cancer treatment (https://ibn.fm/Es52b). Data from…

MondayDec 20, 2021 11:59 am

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Partners with Leading Mechanical, Plant Engineering Firm

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is partnering with Dürr, one of the world's leading mechanical and plant engineering firms. Durr brings extensive expertise in automation and digitalization to the partnership, which is designed to focus on MULN’s EV manufacturing footprint. According to the agreement, Dürr, which has extensive expertise in automation and digitalization, will support Mullen’s Advanced Manufacturing and Engineering Center (“AMEC”) with full integration for vehicle assembly and complete paint shop technologies; the engineering center is located in Tunica, Mississippi. "Dürr is a leading international manufacturing systems and technology provider for the automotive industry,”…

MondayDec 20, 2021 11:49 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), an Undervalued Opportunity for Investment

Mydecine’s and CMPS’ stocks have been grossly undervalued largely due to a lack of understanding of the psychedelic space The situation presents a unique opportunity for investment, as Roth Capital Partners issued a $3 buy rating for 2022 Mydecine has put systems and infrastructure in place to bank on the growing PTSD treatment, smoking cessation, and the health and wellness apps market, in its drive to increase value for its shareholders There has been a huge misunderstanding of the psychedelic space and the potential that this industry has, specifically regarding the treatment of Post-Traumatic Stress Disorder (“PTSD”) and smoking cessation.…

MondayDec 20, 2021 11:39 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces General Meeting Voting, Publication of Key Article on CBN as Possible Glaucoma Treatment

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, held its general meeting on Dec. 17, 2021, and approved the election of all director nominees. Those elected will hold office until the next annual shareholder meeting or until their successors are elected or appointed. The company also noted that all of the matters outlined for consideration and approval in InMed’s notice of meeting and management information circular were approved. In addition, the company announced that an article discussing cannabinol (“CBN”) as a potential treatment option for glaucoma has been published in a peer-reviewed journal.…

FridayDec 17, 2021 2:46 pm

QualityStocksNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Focused on Florida Ahead of ‘Massive Medical Marijuana Boom’

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis sector operator, is off to a strong start in building its high-quality flower resource for product inventory at dispensaries throughout Florida. The company has been working to launch growing operations at its Apopka, Florida-based cultivation location, adding 19,200 square feet of production expected to deliver $30 million in annual revenues. The pods were approved by the state health department’s Office of Medical Marijuana Use (“OMMU”) with licensing granted just before Halloween, with five already in use for plant growth at that time with the remainder fast-tracked for output.…

FridayDec 17, 2021 2:23 pm

QualityStocksNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Advancing MYCO-001 to Bring Safer, More Effective Smoking Cessation Treatment to Market

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, today published a blog article discussing positive clinical data assessing psilocybin for smoking cessation and its upcoming clinical trials. The piece, titled “Why We’re Bullish on MYCO-001, 99% Psilocybin, to Treat Nicotine Dependance,” covers Mydecine’s partnership with Dr. Matthew Johnson and Johns Hopkins University to advance its lead drug candidate MYCO-001 as a smoking cessation treatment. The company’s phase 2/3 smoking cessation clinical trial, set to launch in early 2022, builds from Dr. Johnson’s previous research…

FridayDec 17, 2021 2:09 pm

QualityStocksNewsBreaks – FingerMotion Inc. (FNGR) Anticipates Early 2022 Operationalization of Its Latest Insurtech Services

FingerMotion (OTCQX: FNGR) is playing a part in the growth of insurtech, an industry that has turned 2021 into a record year for business with deals that have already outpaced all of 2020, by approximately 48%, as of the end of the third quarter. FingerMotion inked a big data outlook deal with global insurer Pacific Life early in the year to provide data analytics for Pacific Life’s Re-insurance division. The company also added two brands that will generate value-add underwriting services by covering mobile consumer device maintenance needs. “FingerMotion’s revenue generator is its mobile device tech services division, which grew…

FridayDec 17, 2021 1:43 pm

QualityStocksNewsBreaks – DigiMax Global Inc. (CSE: DIGI) (OTC: DBKSF), BearClaw Bringing CryptoHawk AI Products to Growing Generation Desiring Tech Advancement

DigiMax Global (CSE: DIGI) (OTC: DBKSF) recently entered a partnership with BearClaw Esports, introducing the gaming industry to its cryptocurrency expertise. This further positions the company since, according to MarketWatch, video games have emerged as a larger industry than sports and movies combined as a result the global pandemic (https://ibn.fm/S80JK). The new partnership will provide BearClaw’s community of Esports followers and streaming gamers with access to CryptoHawk AI products and information. “Esports gamers are well known for their affiliation with cryptocurrencies, with many gamers also using their computer hardware to mine and trade a wide variety of cryptocurrencies,” reads a recent…

FridayDec 17, 2021 12:37 pm

QualityStocksNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Set to Benefit from Enactment of FDA-Proposed OTC Hearing Aids Law

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, recently launched its world-class hearing aids and related products on multiple websites. InnerScope has partnered with the online retailer and industry leader in the U.S. tax-free health care market. Furthermore, its hearing aids and other portfolio products qualify as eligible for flexible spending accounts (“FSA”) and health saving account users, and InnerScope is the only company on the retailers’ websites to offer hearing aids. InnerScope has also acquired iHEAR Medical Inc. and struck another major deal, inking a letter of intent to acquire…

FridayDec 17, 2021 12:10 pm

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Focused on Improving Patient Outcomes, Lowering Overall Health Care Costs

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is celebrating the achievement of key milestones this year, which include an agreement with Abbott Diagnostics to establish in-store kiosks that utilize Avricore’s platform. This builds on an agreement with the Shoppers Drug Mart pharmaceutical chain that makes its platform accessible to patients across Canada. Avricore’s HealthTab(TM) platform is a testing and health data network that draws on data from blood samples and other samples to provide lab-quality results to patients in real-time. “Avricore’s efforts to provide access to the testing solution makes it possible for patients to seek out pharmacies in their local…

Site Search

Company Search